One of the hottest retention factors in 2025 comes with a big cost
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Ozempic, Wegovy coverage demand adds to employer health-insurance costs
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Medifast, Inc. (NYSE:MED) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 18, 2025 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $-0.16. Operator: Greetings and welcome to the Medifast Fourth ...
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansions
Q4 2024 Management View CEO Dan Chard highlighted that 2024 was a transformative year for Medifast due to the increasing adoption of GLP-1 weight loss medications. The company is adapting to these ...
Focus: Next generation weight loss drugs aim to save muscle
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...
News Medical on MSN4h
Regulatory crackdown on online prescriptions of weight-loss drugs
Online pharmacies must now conduct in-person consultations before dispensing weight-loss medications, ensuring safe and appropriate use of high-risk drugs.
Medicare beneficiaries face much higher drug costs as plans quickly shift to co-insurance
Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...